Language:
English
繁體中文
Help
回圖書館
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Risk regulation in the single market...
~
Krapohl, Sebastian, (1978-)
Risk regulation in the single market = the governance of pharmaceuticals and foodstuffs in the European Union /
Record Type:
Electronic resources : Monograph/item
Title/Author:
Risk regulation in the single market/ Sebastian Krapohl.
Reminder of title:
the governance of pharmaceuticals and foodstuffs in the European Union /
Author:
Krapohl, Sebastian,
Published:
Basingstoke [England] ;Palgrave Macmillan, : 2008.,
Description:
xiii, 225 p. :ill. ; : 23 cm.;
Notes:
Originally presented as the author's dissertation (doctoral)--Universitèat Bamberg, 2007.
Series:
Palgrave studies in European Union politics
Subject:
Food law and legislation - European Union countries. -
Online resource:
access to fulltext (Palgrave)
ISBN:
9780230584044
Risk regulation in the single market = the governance of pharmaceuticals and foodstuffs in the European Union /
Krapohl, Sebastian,1978-
Risk regulation in the single market
the governance of pharmaceuticals and foodstuffs in the European Union /[electronic resource] :Sebastian Krapohl. - Basingstoke [England] ;Palgrave Macmillan,2008. - xiii, 225 p. :ill. ;23 cm. - Palgrave studies in European Union politics.
Originally presented as the author's dissertation (doctoral)--Universitèat Bamberg, 2007.
Includes bibliographical references (p. 195-220) and index.
Introduction : the need for a systematic analysis of supranational risk regulation -- Functional pressure and path-dependencies : the emergence and development of supranational regulatory regimes -- Efficiency and legitimacy : the evaluation of supranational regulatory regimes -- From national crises to a strong supranational regime : the developmentof pharmaceutical authorisation in Europe-- A strong regulatory regulatory network : -- The evaluation of the European regulatory regime forpharmaceuticals -- From an early single market to a crisis of consumerconfidence : the development of foodstuff regulation in Europe -- A weak supranational agency : the evaluation of the European regulatory regime for foodstuffs -- A comparison of pharmaceutical and foodstuff regulation in Europe.
Why do the regulatory institutions of the EU look different across similar policy areas? Why do they work with different degrees of success? This book provides a theoretically driven comparisonof two importantareas of EU risk regulation. Whereas the functional demands for supranational risk regulation are similar in pharmaceutical and foodstuff regulation, the efficiency of the two respective regulatory regimes has differed widely during the last 15 years. The EU regulatory regime for pharmaceuticals has managed to establish a single market for highly innovative pharmaceuticals - including b1 sred biotechnology b2 s. In contrast, the single market for foodstuffs was shattered by theBSE crisis, and b1 sgreen biotechnology b2 s - that is, GMOs and Gen-Food - is still highly contested. As this book demonstrates, these differences in the efficiency and legitimacy of EU risk regulation can be traced back tothe different institutional designs of the respective regimes, which in turn result from different developmental paths.
Electronic reproduction.
Basingstoke, England :
Palgrave Macmillan,
2009.
Mode of access:World Wide Web.
ISBN: 9780230584044
Standard No.: 10.1057/9780230584044doiSubjects--Topical Terms:
306655
Food law and legislation
--European Union countries.Index Terms--Genre/Form:
96803
Electronic books.
LC Class. No.: KJE6778 / .K73 2008eb
Dewey Class. No.: 344.2404/232
Risk regulation in the single market = the governance of pharmaceuticals and foodstuffs in the European Union /
LDR
:03360nmm 2200337Ia 4500
001
159200
003
OCoLC
005
20100709081748.0
006
m d
007
cr cn|
008
160219s2008 enka sb 001 0 eng d
020
$a
9780230584044
020
$a
0230584047
024
7
$a
10.1057/9780230584044
$2
doi
035
$a
(OCoLC)314828560
035
$a
ocn314828560
040
$a
UKPGM
$b
eng
$c
UKPGM
043
$a
e------
049
$a
APTA
050
1 4
$a
KJE6778
$b
.K73 2008eb
082
0 4
$a
344.2404/232
$2
22
100
1
$a
Krapohl, Sebastian,
$d
1978-
$3
306654
245
1 0
$a
Risk regulation in the single market
$h
[electronic resource] :
$b
the governance of pharmaceuticals and foodstuffs in the European Union /
$c
Sebastian Krapohl.
260
$a
Basingstoke [England] ;
$a
New York :
$c
2008.
$b
Palgrave Macmillan,
300
$a
xiii, 225 p. :
$b
ill. ;
$c
23 cm.
440
0
$a
Palgrave studies in European Union politics
500
$a
Originally presented as the author's dissertation (doctoral)--Universitèat Bamberg, 2007.
504
$a
Includes bibliographical references (p. 195-220) and index.
505
0
$a
Introduction : the need for a systematic analysis of supranational risk regulation -- Functional pressure and path-dependencies : the emergence and development of supranational regulatory regimes -- Efficiency and legitimacy : the evaluation of supranational regulatory regimes -- From national crises to a strong supranational regime : the developmentof pharmaceutical authorisation in Europe-- A strong regulatory regulatory network : -- The evaluation of the European regulatory regime forpharmaceuticals -- From an early single market to a crisis of consumerconfidence : the development of foodstuff regulation in Europe -- A weak supranational agency : the evaluation of the European regulatory regime for foodstuffs -- A comparison of pharmaceutical and foodstuff regulation in Europe.
520
$a
Why do the regulatory institutions of the EU look different across similar policy areas? Why do they work with different degrees of success? This book provides a theoretically driven comparisonof two importantareas of EU risk regulation. Whereas the functional demands for supranational risk regulation are similar in pharmaceutical and foodstuff regulation, the efficiency of the two respective regulatory regimes has differed widely during the last 15 years. The EU regulatory regime for pharmaceuticals has managed to establish a single market for highly innovative pharmaceuticals - including b1 sred biotechnology b2 s. In contrast, the single market for foodstuffs was shattered by theBSE crisis, and b1 sgreen biotechnology b2 s - that is, GMOs and Gen-Food - is still highly contested. As this book demonstrates, these differences in the efficiency and legitimacy of EU risk regulation can be traced back tothe different institutional designs of the respective regimes, which in turn result from different developmental paths.
533
$a
Electronic reproduction.
$b
Basingstoke, England :
$c
Palgrave Macmillan,
$d
2009.
$n
Mode of access:World Wide Web.
$n
System requirements: Web browser.
$n
Title from title screen (viewed on Mar. 3, 2009).
$n
Access may berestricted to users at subscribing institutions.
650
0
$a
Food law and legislation
$z
European Union countries.
$3
306655
650
0
$a
Drugs
$x
Law and legislation
$z
European Union countries.
$3
306656
655
7
$a
Electronic books.
$2
local.
$3
96803
710
2
$a
Palgrave Connect (Online service)
$3
227469
776
1
$c
Original
$z
9780230537651
$z
0230537650
$w
(DLC) 2008030198
$w
(OCoLC)236082328
856
4 0
$3
Palgrave Connect
$u
http://www.palgraveconnect.com/doifinder/10.1057/9780230584044
$z
access to fulltext (Palgrave)
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login